Biotech · Private company · Syracuse, NY, US

Dub Therapeutics Inc.

Track this companyFree. Adds Dub Therapeutics Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomyFiscal year 2026 · $1MNIH RePORTER 5R44EY038138-02 · fetched Nov 12, 2026
A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomyFiscal year 2025 · $1MNIH RePORTER 1R44EY038138-01 · fetched Nov 12, 2026
A single dose anti-scarring therapeutic for the corneaFiscal year 2024 · $182KNIH RePORTER 3R44EY035188-02S1 · fetched Nov 12, 2026
A single dose anti-scarring therapeutic for the corneaFiscal year 2024 · $917.9KNIH RePORTER 5R44EY035188-02 · fetched Nov 12, 2026